文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

导管原位癌根治性治疗后对侧乳腺癌:发生率及相关临床病理和影像学危险因素。

Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors.

机构信息

Division of Breast Imaging, Department of Radiology, Massachusetts General Hospital, 55 Fruit Street (WAC 240), Boston, MA 02114, USA.

Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Clin Imaging. 2022 Feb;82:179-192. doi: 10.1016/j.clinimag.2021.11.018. Epub 2021 Nov 20.


DOI:10.1016/j.clinimag.2021.11.018
PMID:34872008
Abstract

PURPOSE: Patients who have ductal carcinoma in situ (DCIS) are undergoing bilateral mastectomy at increasing rates. One of the reasons is to minimize contralateral breast cancer (CBC) risk. The purpose of this study is to determine the rate of and risk factors associated with CBC in women treated for DCIS. METHODS: A retrospective study was performed of women with DCIS at surgery from 2007 to 2014 who had at least five-year follow-up. Patient attributes, imaging findings, histopathology results, and surgical and long-term outcomes were collected. Features associated with a CBC were assessed with multivariable logistic regression models. RESULTS: 613 women (mean 56 years, range 30-87) with DCIS underwent breast-conserving surgery (BCS) (n = 426), unilateral mastectomy (n = 101), or bilateral mastectomy (n = 86), with mean follow-up of 7.9 years. Of the 527 women who had BCS or unilateral mastectomy, 7.4% (n = 39) developed a CBC (DCIS in 12 and invasive cancer in 27). 4.1% (5/122) of women treated with adjuvant endocrine therapy developed a CBC, compared to 8.4% (34/405) who were not treated (p = .11). Features associated with CBC risk were younger age at menarche (adjusted odds ratio [aOR] of 0.76, p = .03) and low nuclear grade of DCIS (aOR of 5.43 for grade 1 versus 3, p = .01). CONCLUSION: In women treated for DCIS, the overall rate of CBC was low at 7.4%. Younger age at menarche and low nuclear grade of DCIS had significant associations with higher CBC risk.

摘要

目的:患有导管原位癌(DCIS)的患者正在以越来越高的比例接受双侧乳房切除术。原因之一是为了最大限度地降低对侧乳腺癌(CBC)的风险。本研究的目的是确定在接受 DCIS 治疗的女性中 CBC 的发生率和相关风险因素。

方法:对 2007 年至 2014 年接受手术治疗的 DCIS 女性患者进行回顾性研究,这些患者的随访时间至少为 5 年。收集患者特征、影像学表现、组织病理学结果以及手术和长期结果。使用多变量逻辑回归模型评估与 CBC 相关的特征。

结果:613 名(平均年龄 56 岁,范围 30-87 岁)患有 DCIS 的女性接受了保乳手术(BCS)(n=426)、单侧乳房切除术(n=101)或双侧乳房切除术(n=86),平均随访时间为 7.9 年。在接受 BCS 或单侧乳房切除术的 527 名女性中,7.4%(n=39)发生了 CBC(DCIS 12 例,浸润性癌 27 例)。接受辅助内分泌治疗的 122 名女性中有 4.1%(5/122)发生了 CBC,而未接受治疗的 405 名女性中有 8.4%(34/405)发生了 CBC(p=0.11)。与 CBC 风险相关的特征是初潮年龄较小(调整后的优势比 [aOR]为 0.76,p=0.03)和 DCIS 的核分级较低(核分级 1 与 3 相比,aOR 为 5.43,p=0.01)。

结论:在接受 DCIS 治疗的女性中,CBC 的总体发生率较低,为 7.4%。初潮年龄较小和 DCIS 的核分级较低与 CBC 风险显著相关。

相似文献

[1]
Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors.

Clin Imaging. 2022-2

[2]
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.

Breast Cancer Res Treat. 2021-4

[3]
Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?

Ann Surg Oncol. 2017-8-1

[4]
Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.

Ann Surg Oncol. 2019-9-24

[5]
Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era.

Am J Surg. 2021-3

[6]
Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.

Ann Surg Oncol. 2015-10

[7]
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.

World J Surg Oncol. 2016-4-27

[8]
Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.

JAMA Surg. 2017-4-1

[9]
Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.

Breast Cancer Res Treat. 2019-9-6

[10]
Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.

Breast. 2022-6

引用本文的文献

[1]
Prediction of Surgical Upstaging Risk of Ductal Carcinoma In Situ Using Machine Learning Models.

J Breast Imaging. 2023-10-17

[2]
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.

Breast Cancer Res Treat. 2023-11

[3]
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.

Breast Care (Basel). 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索